Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial ...

A research team led by Lee Dae-in and Kang Dong-oh at Korea University Guro Hospital Cardiovascular Center and Kim Sun-won at Korea University Ansan Hospital Cardiovascular Center confirmed that even ...

According to research conducted by Brazilian scientists, high glucose levels may serve as a biomarker indicating a worse outcome in patients who have experienced their first acute myocardial ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...

Brown, TM ∙ Hernandez, AF ∙ Bittner, V ∙ et al., the American Heart Association Get With The Guidelines Investigators Predictors of cardiac rehabilitation referral in coronary artery disease patients: ...

We preselected all newsletters you had before unsubscribing.

A pioneering study by researchers from Finland and the UK has demonstrated for the first time that myocardial infarction may be an infectious disease. This discovery challenges the conventional ...

Ankylosing spondylitis (AS) is increasingly recognized as an independent risk factor for premature myocardial infarction (MI), yet the molecular bridge linking chronic axial inflammation to acute ...

PF pathogenesis involves alveolar epithelial cell injury, profibrotic mediators, and dysregulated non-coding RNAs, complicating disease management. Current treatments, including pirfenidone and ...

Objective: To investigate the etiology and clinical characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) in the Qinghai-Tibet Plateau region. Methods: ...